179 related articles for article (PubMed ID: 11353047)
1. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases.
Brien TP; Farraye FA; Odze RD
Mod Pathol; 2001 May; 14(5):389-96. PubMed ID: 11353047
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer.
Kitamura K; Saeki H; Kawaguchi H; Araki K; Ohno S; Kuwano H; Maehara Y; Sugimachi K
Hepatogastroenterology; 2000; 47(32):419-23. PubMed ID: 10791203
[TBL] [Abstract][Full Text] [Related]
5. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.
Teh M; Tan KB; Seet BL; Yeoh KG
Cancer; 2002 Aug; 95(3):499-505. PubMed ID: 12209741
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
7. [High and low grade gastric epithelial dysplasia: clinical management, endoscopic assessment of p53].
Testino G; Cornaggia M; De Iaco F; Gada D
Ann Ital Med Int; 2003; 18(4):231-7. PubMed ID: 14971711
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus.
Monges GM; Seitz JF; Giovannini MF; Gouvernet JM; Torrente MA; Hassoun JA
Cancer Detect Prev; 1996; 20(1):63-7. PubMed ID: 8907205
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
10. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
[TBL] [Abstract][Full Text] [Related]
12. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
13. Low- and high-grade non-invasive gastric neoplasia (formerly dysplasia): cytological differentiation (gastro-entero-pancreatic antigens) in association with p53 pattern expression.
Testino G; Cornaggia M; Ferrando V
Hepatogastroenterology; 2007; 54(73):1-3. PubMed ID: 17419219
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
[TBL] [Abstract][Full Text] [Related]
15. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
Rohatgi P; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Roth JA; Ajani JA
Cancer; 2005 Dec; 104(11):2365-72. PubMed ID: 16245310
[TBL] [Abstract][Full Text] [Related]
17. Collision carcinoma of the residual cervical esophagus 27 years after esophageal cancer surgery.
Naritaka Y; Ogawa K; Shimakawa T; Wagatsuma Y; Isohata N; Asaka S; Miyaki A; Shiozawa S; Katsube T; Yoshimatsu K; Aiba M; Ide H
Anticancer Res; 2007; 27(1B):505-11. PubMed ID: 17348434
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma.
Ghandur-Mnaymneh L; Paz J; Roldan E; Cassady J
Am J Surg Pathol; 1988 Feb; 12(2):96-114. PubMed ID: 3341515
[TBL] [Abstract][Full Text] [Related]
19. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
Heeren PA; Kloppenberg FW; Hollema H; Mulder NH; Nap RE; Plukker JT
Anticancer Res; 2004; 24(4):2579-83. PubMed ID: 15330218
[TBL] [Abstract][Full Text] [Related]
20. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
Chen ZM; Scudiere JR; Abraham SC; Montgomery E
Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
